Labcorp Q2 FY25: where the revenue came from and where it went
The whole income statement of Labcorp for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Apr 1 – Jun 30, 2025
- Reported
- Aug 1, 2025
Revenue$3.53B
+10% year over year
Gross profit$1.05B
30% margin
Operating profit$0.40B
11% margin
Net profit$0.24B
7% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 3.53 | 100% | +10% |
| Diagnostics | 2.75 | 78% | +9% |
| Biopharma laboratory | 0.79 | 22% | +11% |
| Cost of revenue | −2.48 | 70% | |
| Gross profit | 1.05 | 30% margin | +1pp |
| SG&A | −0.58 | 16% | −1pp |
| Other | −0.07 | 2% | +0pp |
| Operating profit | 0.40 | 11% margin | +2pp |
| Interest & other costs | −0.09 | ||
| Tax | −0.07 | ||
| Net profit | 0.24 | 7% margin | +0pp |
122 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest